Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-20

Clinical Trial Update: Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing efficacy and safety of pyronaridine-artesunate for uncomplicated falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyronaridine-artesunate (pyronaridine/artesunate)

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Falciparum | Phase 2 | Status: COMPLETED